Table 1.
Univariate and multivariate analysis of clinicopathological factors affecting overall survival rate in colorectal cancer patients
| Factor | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| RR | 95% CI | P value | RR | 95% CI | P value | |
| Age, >65/≤65 years | 1.853 | 0.843‐4.178 | .124 | – | – | – |
| Sex, male/female | 2.027 | 0.856‐5.568 | .112 | – | – | – |
| Histology grade: well, moderate/others | 0.188 | 0.071‐0.651 | .012* | 0.275 | 0.091‐1.059 | .059 |
| T factor, ≤SS/≥SE | 0.193 | 0.078‐0.438 | <.001* | 0.512 | 0.181‐1.389 | .189 |
| Lymph node metastasis, absent/present | 0.189 | 0.069‐0.449 | <.001* | 0.581 | 0.187‐1.669 | .314 |
| Lymphatic invasion, absent/present | 0.349 | 0.154‐0.768 | .009* | 0.633 | 0.235‐1.703 | .362 |
| Venous invasion, absent/present | 0.225 | 0.101‐0.534 | .001* | 0.392 | 0.144‐1.072 | .068 |
| Liver metastasis, absent/present | 0.091 | 0.041‐0.219 | <.001* | 0.229 | 0.074‐0.691 | .009* |
| GTF2IRD1 mRNA expression, low/high | 0.269 | 0.089‐0.664 | .003* | 0.336 | 0.103‐0.914 | .032* |
Abbreviations: CI, confidence interval; RR, relative risk; SE, serosa; SS, subserosa.
*
Statistically significant.